EPO Patents = 2

Forward Citations = 11

Loading Chart...

3 inventors (with patents filed for the assignee):

Olivier D Boss (6 out of 8 patents)

Jean-Paul Giacobino (5 out of 7 patents)

Mihaela Crisan (2 out of 2 patents)

4. P Scott Gullicksen (0 patent)

5. P Scott Gullicksen (0 patent)

6 patents: Sort by Forward Citations

1. 12025612 - Brown adipocyte progenitors in human skeletal muscle (2024-07-02),

2. 11419916 - Methods and compositions for inducing differentiation of human brown adipocyte progenitors (2022-08-23),

3. 11299710 - Brown adipocyte progenitors in human skeletal muscle (2022-04-12),

4. 10301595 - Brown adipocyte progenitors in human skeletal muscle (2019-05-28),

5. 9410945 - Brown adipocyte progenitors in human skeletal muscle (2016-08-09),

6. 8455204 - Brown adipocyte progenitors in human skeletal muscle and methods for identifying differentiation agents therefor (2013-06-04),

Company Overview

Energesis Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for metabolic diseases. With a strong pipeline of novel drug candidates, Energesis aims to address unmet medical needs in areas such as diabetes, obesity, and metabolic syndrome. Our team of scientists and researchers are dedicated to advancing these promising treatments to improve the lives of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#324 in Cambridge, MA

#2,545 in Massachusetts

#44,981 in US

Cambridge, MA, United States of America

Energesis Pharmaceuticals, Inc.

Forward Citations = 11

3 inventors:

Olivier D Boss (6 out of 8 patents)

Jean-Paul Giacobino (5 out of 7 patents)

Mihaela Crisan (2 out of 2 patents)

4. P Scott Gullicksen (0 patent)

5. P Scott Gullicksen (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Energesis Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/energesis-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]